Instructions Enterosgel with sweet taste paste for oral use container 135 g
Composition
active ingredient: 100 g contains methylsilicic acid hydrogel – 69.9 g;
Excipients: saccharin sodium dihydrate, sodium cyclamate, purified water.
Dosage form
Paste for oral use.
Main physicochemical properties: homogeneous pasty mass of white color, odorless.
Pharmacotherapeutic group
Enterosorbents. ATX code A07V S.
Pharmacological properties
Pharmacodynamics
Enterosgel is an inert organic silicon compound. When used, it exhibits a sorption effect. The drug effectively adsorbs medium-molecular toxic substances of exo- and endogenous origin, products of incomplete metabolism, incorporated radionuclides and naturally removes them from the body. Enterosgel eliminates the manifestations of toxicosis, improves intestinal function, detoxifying function of the liver and kidneys, normalizes blood and urine parameters.
Pharmacokinetics
By covering the mucous membrane of the stomach and intestines, Enterosgel protects it from erosive processes, helps to increase local immunity. Enterosgel is not absorbed from the intestines and does not undergo metabolic or chemical transformations.
Indication
Detoxification of the body in chronic renal failure caused by pyelonephritis, polycystic kidney disease, nephrolithiasis; in toxic hepatitis, viral hepatitis A and B, cholecystitis, cirrhosis of the liver, cholestasis of various etiologies, gastritis with low acidity, enterocolitis, colitis, diarrhea; in alcohol and drug poisoning; in allergic reactions, skin diseases (diathesis, neurodermatitis); in burn disease; purulent-septic processes; toxicosis of the first half of pregnancy; in the complex therapy of intestinal dysbiosis.
Contraindication
Acute intestinal obstruction. Hypersensitivity to the components of the drug.
Interaction with other medicinal products and other types of interactions
The drug may reduce the effect of other drugs used with it. Simultaneous administration with drugs belonging to the class of bile acid sequestrants, such as cholestyramine, is not recommended due to the increased likelihood of constipation.
The drug should not be used together with silver preparations.
Application features
The drug should be taken according to the recommendations set out in this instruction. Provided that the method of administration is followed (Enterosgel and medicines should be taken at an interval of 1.5-2 hours), the drug can be used in complex therapy with other medicinal and prophylactic agents, including prebiotics and probiotics (bifidum, lactobacilli), herbal preparations, adaptogens, immunomodulators.
Use during pregnancy or breastfeeding
The drug can be used during pregnancy or breastfeeding. Use should be limited to pregnant women who are prone to constipation.
Ability to influence reaction speed when driving vehicles or other mechanisms
Does not affect.
Method of administration and doses
Take orally 2-3 times a day 1.5-2 hours before or 2 hours after meals or other medications, with plenty of water.
For adults and children over 14 years of age, a single dose of the drug is 15 g (tablespoon), daily dose is 45 g.
For children from birth to 3 years, a single dose of the drug is 5 g (teaspoon), daily - 10 g; from 3 to 5 years - a single dose - 5 g, daily - 15 g; from 5 to 14 years - a single dose - 10 g (dessert spoon), daily - 30 g.
The course of treatment is from 7 to 14 days. In severe forms of the disease, a double single dose should be used during the first three days, and in the case of a chronic course of the disease (chronic renal failure, cirrhosis of the liver), longer use of the drug is possible.
Children
The drug can be used in children from birth. For children under 2 years of age, a single dose of the drug can be mixed with a small amount of water before use.
Overdose
No cases of overdose have been described. In case of overdose, side effects may be aggravated.
Adverse reactions
When taking the drug, dyspeptic phenomena are possible. In the first days of taking the drug, constipation may develop. To prevent it, people prone to constipation are recommended to perform a cleansing enema at night or use laxatives (lactulose, sodium picosulfate) in the first two days of taking the drug. Hypersensitivity reactions are possible.
Expiration date
2 years.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C, do not freeze. After opening the package, store under the same conditions in a tightly closed container.
Packaging
135 g or 270 g, or 405 g in plastic containers, 15 g in bags No. 10 or No. 20.
Vacation category
Without a prescription.
Producer
PJSC KREOMA-PHARM.
03680, Ukraine, Kyiv, Radyshcheva St., 3.
